NOT-TR-23-002: Notice of Termination for NOT-TR-22-023 NCATS Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)

Notice of Termination for NOT-TR-22-023 NCATS Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)

Notice Number:

NOT-TR-23-002

Key Dates

Release Date:

October 25, 2022

Related Announcements

PAR-21-340 - Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)

NOT-TR-22-023 - Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)

NOT-TR-23-003 - Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this notice is to announce that effective immediately, the Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2), NOT-TR-22-023 is terminated. The National Center for Advancing Translational Sciences (NCATS) will reissue this Notice of Special Interest as NOT-TR-23-003.

Inquiries

Please direct all inquiries to:

Pablo Cure
National Center for Advancing Translational Sciences
Telephone: 301-827-2014
Email: [email protected]